Novartis AG
Polyomavirus neutralizing antibodies
Last updated:
Abstract:
The present invention relates to anti-polyomavirus antibodies, antibody fragments, and their uses for the prevention and treatment of BK or JC virus infection and associated diseases.
Status:
Grant
Type:
Utility
Filling date:
28 Nov 2018
Issue date:
6 Sep 2022